Pfizer inc (PFE) Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Pfizer inc (NYSE: PFE) FY 2026 Other Release

Newsdesk: